Pre-market Hot Trades in US Stocks
Guardant Health is down 10.13% in pre-market trading. Based on recent key news:
<ol>
<li>
On May 4, Guardant Health received FDA approval for its Guardant360® CDx as a companion diagnostic tool for Arvinas and Pfizer's VEPPANU (vepdegestrant) to detect ESR1 mutations in ER+/HER2- advanced breast cancer patients. This approval expands the application of Guardant360 CDx and drove the stock price up by 1.3%.
</li>
<li>
On May 4, Guardant Health Chairman and Co-CEO Helmy Eltoukhy stated that the latest FDA approval reflects the direction of cancer care, enabling early detection of resistance through blood tests and guiding smarter treatment decisions. This news further boosted market confidence in the company's future development.
</li>
<li>
On May 2, MarketBeat reported that although Guardant Health currently has a moderate buy rating among analysts, top analysts believe there are five stocks more worthy of purchase than Guardant Health. This news may have a negative impact on the stock price. FDA approval expands applications, enhancing market confidence.
</li>
</ol>
Fabrinet is down 9.72% in pre-market trading. Based on recent key news:
<ol>
<li>
On May 4, Fabrinet released its first-quarter financial report, exceeding market expectations. The company reported earnings per share of $3.72, higher than the expected $3.56, with quarterly revenue of $1.21 billion, surpassing the expected $1.18 billion. This performance led to a 10.84% drop in the stock price in after-hours trading. Source: Benzinga
</li>
<li>
On May 4, JP Morgan analyst Samik Chatterjee downgraded Fabrinet's rating from overweight to neutral and raised the target price from $530 to $700. The analyst's rating adjustment may have negatively impacted the stock price. Source: JP Morgan
</li>
<li>
On May 5, Fabrinet expects adjusted earnings per share for the fourth quarter to be between $3.72 and $3.87, with revenue between $1.25 billion and $1.29 billion, slightly below market expectations. This outlook may lead to investor concerns about future performance. Source: Benzinga The electronic equipment industry has shown recent volatility, and supply chain risks need to be monitored.
</li>
</ol>
Top Gainers in Pre-market US Stocks
Sadot is up 122.17% in pre-market trading. Based on recent key news:
<ol>
<li>On May 3, Four Pillars raised funds in its Series A financing, although the specific amount was not disclosed. As a research-driven blockchain company, Four Pillars helps businesses efficiently implement blockchain technology, providing technical, legal, and market analysis support
This news may boost market confidence in blockchain-related companies, driving a significant increase in Sadot's stock price. The blockchain industry has performed strongly recently, with noticeable capital inflows.</li>
</ol>
3 E Network Tech rose 64.17% in pre-market trading. Based on recent key news:
<ol>
<li>
On May 4th, 3 E Network Technology Group announced the signing of a $1.3 million convertible bond agreement with an institutional investor. This agreement includes an initial closing of $920,000 and provides for a potential second tranche of $300,000, subject to conditions. Following this announcement, the stock price surged.
</li>
<li>
On May 4th, 3 E Network Technology Group published original content on GlobeNewswire detailing the specific terms and details of the aforementioned agreement, further enhancing market confidence.
</li>
<li>
On May 4th, 3 E Network Technology Group stated that the agreement also includes warrants for stock purchases, and the bonds have an 8% original issue discount. These favorable terms attracted investors, driving the stock price up. Recent technology stocks have performed strongly, with noticeable capital inflows.
</li>
</ol>
Acorn Energy rose 53.23% in pre-market trading. Based on recent key news:
<ol>
<li>
On May 2nd, Acorn Energy announced that it will release its Q1 2026 financial report on May 7th and hold a conference call. This news sparked positive market expectations regarding the company's performance, driving a significant increase in the stock price.
</li>
<li>
On May 1st, Acorn's subsidiary OmniMetrix excelled in the field of wireless remote monitoring and control solutions for critical infrastructure, serving top companies across multiple industries. This information enhanced investor confidence in the company's future growth potential.
</li>
<li>
On May 2nd, Acorn's conference call on May 7th provides investors with an opportunity to understand the company's Q1 performance, further increasing market attention on its financial updates. Growing interest in technology stocks has driven the stock price up
</li>
</ol>

Guardant Health pre-market down 10.13%; Fabrinet pre-market down 9.72%; Sadot pre-market up 122.17%; 3 E Network Tech pre-market up 64.17%; Acorn Energy pre-market up 53.23%

Price Alert

Guardant Health

Pre-market hot trades in US stocks: Guardant Health pre-market down 10.13%; Fabrinet pre-market down 9.72%